39 related items for PubMed ID: 11773989
1. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Rake EC, Breeze E, Fletcher AE.
J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
[Abstract] [Full Text] [Related]
2. Correspondence Regarding Lee et al.: Placebo Control is Vital in Assessing Therapy in Chronic Cough.
Zhang M, Morice A.
Lung; 2024 Jul 02. PubMed ID: 38955862
[No Abstract] [Full Text] [Related]
3. Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital.
Gebreyohannes EA, Bhagavathula AS, Abebe TB, Tefera YG, Abegaz TM.
Clin Hypertens; 2019 Jul 02; 25():1. PubMed ID: 30675379
[Abstract] [Full Text] [Related]
4. Antihypertensive effects and safety of eprosartan: a meta-analysis of randomized controlled trials.
Xu FY, Yang B, Shi D, Li H, Zou Z, Shi XY.
Eur J Clin Pharmacol; 2012 Feb 02; 68(2):195-205. PubMed ID: 21881888
[Abstract] [Full Text] [Related]
5. Eprosartan: a review of its use in the management of hypertension.
Robins GW, Scott LJ.
Drugs; 2005 Feb 02; 65(16):2355-77. PubMed ID: 16266204
[Abstract] [Full Text] [Related]
6. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.
El-Atat F, McFarlane SI, Sowers JR.
Curr Hypertens Rep; 2004 Jun 02; 6(3):215-23. PubMed ID: 15128475
[Abstract] [Full Text] [Related]
7. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Rake EC, Breeze E, Fletcher AE.
J Hum Hypertens; 2001 Dec 02; 15(12):863-7. PubMed ID: 11773989
[Abstract] [Full Text] [Related]
8. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Breeze E, Rake EC, Donoghue MD, Fletcher AE.
J Hum Hypertens; 2001 Dec 02; 15(12):857-62. PubMed ID: 11773988
[Abstract] [Full Text] [Related]
9. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.
Elliott WJ.
J Hum Hypertens; 1999 Jun 02; 13(6):413-7. PubMed ID: 10408592
[Abstract] [Full Text] [Related]
10. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA, Punzi CF.
J Hum Hypertens; 2004 Sep 02; 18(9):655-61. PubMed ID: 15042114
[Abstract] [Full Text] [Related]
11. Management of hypertension: the advent of a new angiotensin II receptor antagonist.
Hedner T.
J Hypertens Suppl; 1999 Jun 02; 17(2):S21-5. PubMed ID: 10465063
[Abstract] [Full Text] [Related]
12. Eprosartan: a review of its use in the management of hypertension.
Plosker GL, Foster RH.
Drugs; 2000 Jul 02; 60(1):177-201. PubMed ID: 10929934
[Abstract] [Full Text] [Related]
13. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Rake EC, Breeze E, Fletcher AE.
J Hum Hypertens; 2001 Dec 02; 15(12):863-7. PubMed ID: 11773989
[Abstract] [Full Text] [Related]
14. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Breeze E, Rake EC, Donoghue MD, Fletcher AE.
J Hum Hypertens; 2001 Dec 02; 15(12):857-62. PubMed ID: 11773988
[Abstract] [Full Text] [Related]
15. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.
Elliott WJ.
J Hum Hypertens; 1999 Jun 02; 13(6):413-7. PubMed ID: 10408592
[Abstract] [Full Text] [Related]
16. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA, Punzi CF.
J Hum Hypertens; 2004 Sep 02; 18(9):655-61. PubMed ID: 15042114
[Abstract] [Full Text] [Related]
17. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
Teitelbaum I, Chilvers M, Reiz RJ.
Can J Cardiol; 2004 Oct 02; 20 Suppl C():11C-16C. PubMed ID: 16807618
[Abstract] [Full Text] [Related]
18. The effect of treatment with eprosartan on pulse pressure: factors predicting response.
de la Sierra A, Muñoz A, Arcos E, López JS, Relats J, ETAPA-2 study investigators.
Can J Cardiol; 2004 Oct 02; 20 Suppl C():17C-22C. PubMed ID: 16807619
[Abstract] [Full Text] [Related]
19. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Rake EC, Breeze E, Fletcher AE.
J Hum Hypertens; 2001 Dec 02; 15(12):863-7. PubMed ID: 11773989
[Abstract] [Full Text] [Related]
20. Management of hypertension: the advent of a new angiotensin II receptor antagonist.
Hedner T.
J Hypertens Suppl; 1999 Jun 02; 17(2):S21-5. PubMed ID: 10465063
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
